Ottawa proposing changes to pharma patent legislation

Guest Contributor
December 21, 2004

The federal government has proposed changes to regulations for the pharmaceutical regulatory environment and has launched a 75-day consultation period. The proposed changes are designed to address key concerns of both the so-called innovative and generic drug manufacturing industries.

... Please become a Member or login to read the rest of this article ...


Other stories mentioning these organizations, people and topics

Other News






Events For Leaders in
Science, Tech, Innovation, and Policy


Discuss and learn from those in the know at our virtual and in-person events.



See Upcoming Events










You have 0 free articles remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in






Top

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.